Remove Business Development Remove Genotoxicity Remove Life Science
article thumbnail

Packaging Solutions for Pharmaceuticals & Medical Devices: Insights and Considerations

XTalks

Aaron Liss, Business Development at Curia, says that CCI testing (CCIT) is “essentially an elaborate term for leak testing performed in a very sensitive and quantitative fashion.” If they do, the FDA will assume the worst-case scenario and deem the compound or fragment to be genotoxic or eugenic.